Fred Lu

全面领导公司生产部门，质量，安全环保和国际销售部。 Lead the global manufacturing division, quality division, EHS and international business group. 翰森制药在全球拥有10000+ 员工，年销售额约120亿元人民币，公司于香港证交所上市，市值约USD15 billion，股票代码03692 10000+ employees worldwide, annual sales of RMB 12 billion， Listed at Hong Kong Stock Exchange with market cap about USD 15 billion. Stock ticker 03692 For more information, please visit: www.hspharm.com

负责年销售40亿元，市值80亿元的医药上市公司长江健康，担任总裁CEO职务（长江健康002435)。同时兼旗下全资子公司海南海灵化学制药有限公司董事长 及 子公司山东华信制药集团股份有限公司执行总裁 全面管理上市公司日常经营，主抓医药板块业务， 管理人数1000+。 As the CEO of Changjiang Health Co., (Parent company of Hailing Pharm with sales of $550 million), led the daily operation of the company and reported to the Board of Directors.

Company Overview: Hainan Hailing Chemipharma Corporation Limited (HailingPharm) was founded in 2004 and located in Haikou City, Hainan Province. It is public listed at China Shenzhen Stock Exchange with the ticker number 002435. It is a high-tech enterprise integrating cutting edge pharmaceutical R&D capability, manufacturing and extensive sales network across China. HailingPharm is engaged in production and distribution of high-quality antibiotics, cardiovascular, gastrointestinal, cream for external use, etc. HailingPharm establishes a complete and extensive distribution network in China. The annual sales exceed USD 350 million. For more details, please go to www.hailingpharm.com. 公司概况： 海灵药业成立于2004年，公司座落于中国海南省海口市。母公司长江健康在深圳证券交易所上市，股票代码002435。公司拥有研发，生产和销售全产业链。 海灵药业产品包括抗细菌，抗病毒，抗真菌，心血管，消化道，外用乳膏剂等医药制剂。在中国拥有丰富而广泛的销售网络。年销售额近30亿人民币. 更多内容，请关注www.hailingpharm.com

Led global product strategy, processes & performance and responsible for the new product launch worldwide. Managed multiple laboratory locations and research teams in the US/Asia and oversaw the partnership with key OEMs. Manage company Quality Control and Quality Assurance teams in the US and Asia.

Led product development team and set company product strategies, costs of project, and equipment and human resource requirements. Oversaw production costs, product quality and inventory to maintain and enhance the profitability of division operation.

Led world class global product marketing team (US, Europe and Asia Pacific) to develop defined product roadmaps and strategies to drive business growth. Led global Technical Application Specialist group to strengthen the industrial presence and technical support to global sales team and customers.

Led the transition of global Nalco chemical & equipment business (US$800 million cooling water business) into the integrated solution by developing automation and service offerings; Developed Nalco global business plan to strengthen Nalco’s leading position in water treatment speciality chemicals business.

Managed Nalco cooling water biocides product line US$250 million; Led cross-functional team to launch next generation stabilized bromine in cooling water application.